Roche Holding AG (OTCMKTS:RHHBY) Receives Average Rating of “Buy” from Analysts

Roche Holding AG (OTCMKTS:RHHBY) has been given an average rating of “Buy” by the six research firms that are presently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, one has issued a buy rating and three have issued a strong buy rating on the company. The average 12-month price objective among brokers that have covered the stock in the last year is $50.00.

A number of brokerages have recently issued reports on RHHBY. Jefferies Financial Group cut Roche from a “hold” rating to a “moderate sell” rating in a report on Monday, October 27th. Morgan Stanley reissued an “underweight” rating on shares of Roche in a report on Wednesday, October 29th. Deutsche Bank Aktiengesellschaft raised Roche from a “sell” rating to a “hold” rating in a report on Tuesday, November 11th. HSBC raised Roche from a “hold” rating to a “buy” rating and set a $50.00 target price for the company in a report on Thursday, October 2nd. Finally, Hsbc Global Res raised shares of Roche from a “hold” rating to a “strong-buy” rating in a research report on Thursday, October 2nd.

Roche Stock Down 0.3%

Shares of RHHBY stock opened at $48.47 on Friday. Roche has a 52 week low of $34.10 and a 52 week high of $49.20. The company has a 50-day simple moving average of $43.81 and a 200 day simple moving average of $41.49.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. S&CO Inc. boosted its stake in shares of Roche by 4.1% in the first quarter. S&CO Inc. now owns 51,199 shares of the company’s stock valued at $2,101,000 after buying an additional 2,014 shares during the period. North Star Asset Management Inc. raised its holdings in Roche by 7.8% in the 1st quarter. North Star Asset Management Inc. now owns 17,305 shares of the company’s stock valued at $712,000 after acquiring an additional 1,255 shares in the last quarter. PNC Financial Services Group Inc. lifted its position in shares of Roche by 2.0% during the 1st quarter. PNC Financial Services Group Inc. now owns 16,234 shares of the company’s stock valued at $668,000 after acquiring an additional 323 shares during the period. Accent Capital Management LLC acquired a new stake in shares of Roche during the 1st quarter worth $35,000. Finally, Everett Harris & Co. CA bought a new position in shares of Roche in the first quarter worth $445,000.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.